BOPA (The British Oncology Pharmacy Association)

What BOPA (The British Oncology Pharmacy Association) does

The British Oncology Pharmacy Association (BOPA) is a registered charity (CIO, Charity No. 1065026) and the dedicated professional membership body for oncology pharmacy professionals in the United Kingdom. Its mission is to standardise competency, advance education, and provide a community for pharmacists and pharmacy technicians working in cancer services, primarily across the NHS. The organisation transitioned to CIO governance following an October 2024 membership vote and is led by an elected Executive Committee headed by Chair Shereen Nabhani-Gebara, with subcommittees, Cancer Advisory Groups, International Groups, and a Fellows programme supporting its activities.

BOPA's core product is the Digital SACT Verification Passport, described as a leading global pharmacy competency training programme for verification of Systemic Anti-Cancer Therapy, rolled out across all four UK devolved nations and provided free to paid members and free associates. Supporting products include an eLearning course catalogue with stop-and-continue modules, BOPA/IOCN drug monographs for immune-related adverse events from checkpoint inhibitors, a Continuing Professional Development course on Health Technology Assessment developed with the University of York and NICE and endorsed by HTAi, a resource library, member forums, the 'Let's Talk About SACT' podcast, and the 29th Annual Conference scheduled for October 2026 at ICC London Olympia. Technology infrastructure is a standard digital membership portal integrating Google Analytics, Vimeo, and SimpleCast, with no disclosed AI/ML capability.

The revenue model rests on three streams: (1) annual individual membership at £65, including passport and e-learning access; (2) one-time conference registration fees at £300 for early-bird members; and (3) corporate membership with separate terms providing access and visibility for pharmaceutical and healthcare companies. Additional income includes the Gilead Sciences-funded Training and Development Grant, awarding 16 funded conference places annually. BOPA reaches members through LinkedIn, Instagram, Facebook, Bluesky, WhatsApp, email newsletters, podcasts, and webinars, with the annual conference as the flagship in-person engagement event.

Name

BOPA (The British Oncology Pharmacy Association)

Legal name

The British Oncology Pharmacy Association

Website

https://bopa.org.uk

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

BOPA is the UK professional membership association for oncology pharmacy, serving pharmacists and pharmacy technicians across the NHS through the SACT Verification Passport, e-learning, drug monographs, HTA CPD courses, and an annual conference.

Ownership category

akta.pro rank

Headquarters

HQ city

United Kingdom

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Annual Membership Fees: Annual membership fee of £65 provides access to the SACT Verification Passport (free for paid members), e-learning modules, resources, forums, and reduced conference fees.
2. Conference Fees: Revenue generated from annual conference registration. BOPA members pay £300 (including VAT) when booked by the early deadline, with non-member pricing higher.
3. Corporate Membership: Corporate membership available for companies, with separate terms and conditions, providing access and visibility to the oncology pharmacy professional community.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

BOPA is a UK professional association that supports oncology pharmacists and pharmacy technicians through an annual membership delivering access to the Digital SACT Verification Passport, CPD-accredited eLearning courses, Health Technology Assessment training, the BOPA/IOCN Drug Monographs for irAEs, member forums, a podcast and resources. It also runs a paid Annual Conference and offers a Corporate Membership scheme for NHS organisations and industry partners, while distributing sponsored grants such as the Gilead-funded Training and Development Grant.

Product overview

BOPA offers a portfolio of professional development and education products for oncology pharmacy professionals in the UK. The core offering is the BOPA Digital SACT Verification Passport, a competency training programme for verification of Systemic Anti-Cancer Therapy. Supporting this are eLearning courses for field-specific certification and CPD, the BOPA/IOCN Drug Monographs for immune-related adverse events, and a Health Technology Assessment CPD course developed with the University of York and NICE. The association also provides community engagement through forums, hosts an annual conference, produces a podcast series, and offers training grants. The products serve the 3,000+ professionals working in NHS pharmacy services across the UK.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Individual Membership Annual subscription product for individual oncology pharmacists and pharmacy technicians that unlocks the BOPA Digital SACT Verification Passport, CPD-accredited eLearning courses, Health Technology Assessment (HTA) CPD course, BOPA/IOCN Drug Monographs for irAEs, member forums, podcasts and online resources. Priced at approximately £65 (early bird) per year for a 12-month period.
• Corporate Membership Bespoke corporate membership scheme for organisations, including NHS pharmacy services and pharmaceutical industry partners, providing dedicated contact with BOPA and engagement with the association's oncology pharmacy network.
• Annual Conference Registration Paid registration for BOPA's flagship Annual Conference, priced separately from membership at approximately £300 for members, with tiered pricing for non-members. The conference serves as the association's main in-person networking and education event for oncology pharmacy professionals.

Quantifiable outcome

• The BOPA Digital SACT Verification Passport has been rolled out successfully across all four devolved nations of the UK and is described as a 'leading global pharmacy competency training programme.'
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core and supporting.

• Gilead SciencescoreStrategic or Co-development Partner · 12 July 2026BOPA is collaborating with Gilead Sciences on the Training and Development Grant, offering 16 funded places to the BOPA 2026 Conference. This includes 5 places for Pharmacy Technicians, 5 for New to Cancer Pharmacy Professionals (<2 years' experience), and 6 Standard Places. Gilead has had no input into the selection of recipients.
• IOCN (International Oncology Cancer Network)coreStrategic or Co-development PartnerBOPA collaborated with IOCN to produce drug monographs for immune-related adverse events (irAEs) related to checkpoint inhibitor use. These monographs support all healthcare professionals in the use of these drugs across solid tumour sites.
• University of YorksupportingImplementation/ SI/ Consulting PartnerThe University of York provided expertise to support the development of BOPA's Health Technology Assessment (HTA) Continuing Professional Development course.
• NICE (National Institute for Health and Care Excellence)supportingImplementation/ SI/ Consulting PartnerNICE provided expertise to support the development of BOPA's Health Technology Assessment (HTA) Continuing Professional Development course.
• Health Technology Assessment International (HTAi)supportingOthersHTAi has endorsed BOPA's Health Technology Assessment (HTA) CPD course. This endorsement provides additional credibility to the course as part of BOPA's passport scheme of core training accreditation.
• BSH Supportive Care Specialist Interest GroupsupportingStrategic or Co-development PartnerBOPA promotes webinars from the British Society for Haematology (BSH) Supportive Care Specialist Interest Group, including a webinar on Consensus methods, which can be applied to co-production of new approaches to care, services or guidelines.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• Xbsky.app/profile/bopa.org.uk
• Facebookfacebook.com/BOPACommittee
• LinkedInlinkedin.com/company/bopa-the-british-oncology-pharmacy-association
• Instagraminstagram.com/bopacommittee

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BOPA (The British Oncology Pharmacy Association)